As per MRFR analysis, the US Positron Emission Tomography Devices Market Size was estimated at 548.1 (USD Million) in 2023. The US Positron Emission Tomography Devices Market Industry is expected to grow from 581.7(USD Million) in 2024 to 1,132.85 (USD Million) by 2035. The US Positron Emission Tomography Devices Market CAGR (growth rate) is expected to be around 6.247% during the forecast period (2025 - 2035).
The US Positron Emission Tomography (PET) devices market is driven by advancements in technology, increased prevalence of diseases such as cancer, and a growing emphasis on early diagnosis and personalized medicine. The integration of artificial intelligence and machine learning in PET imaging is becoming a key market driver, enhancing image quality and reducing the time for diagnosis. Additionally, the rise in government initiatives and funding for research and development in the field of medical imaging is encouraging innovation and adoption of new technologies in the US.
Recent trends indicate a shift toward hybrid imaging systems that combine PET with computed tomography (CT) and magnetic resonance imaging (MRI) for better diagnostic outcomes.This reflects a broader industry move toward comprehensive imaging solutions that provide more accurate and detailed patient information. Alongside this, there is an increasing demand for PET devices that are mobile or compact, allowing for more accessibility in diverse healthcare settings, including outpatient facilities. Opportunities exist in the expansion of PET's application in areas such as neurology and cardiology, where there is growing recognition of the benefits of PET imaging.
The trend of increasingly patient-centered care is also driving demand for technologies that enhance patient comfort and experience during imaging procedures.The US market is witnessing a strong focus on sustainability, with manufacturers exploring eco-friendly materials and processes in the production of PET devices. Overall, these trends collectively highlight an evolving landscape in the US PET devices market, driven by innovation, patient needs, and regulatory support.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Positron Emission Tomography Devices Market Industry is significantly driven by the rising incidence of cancer and cardiovascular diseases across the United States. According to the American Cancer Society, nearly 1.9 million new cancer cases were diagnosed in 2021, and this number is expected to rise each year. The increasing need for accurate diagnosis and efficient treatment monitoring has spurred advancements in imaging technologies like positron emission tomography (PET).
Esteemed organizations such as the National Cancer Institute have underscored the importance of PET scans in oncology, stating that they significantly improve the detection rates of cancerous tissues. As per estimates, the use of advanced imaging technologies is forecasted to yield a 15% increase in demand for PET devices over the next decade as healthcare systems focus on enhancing diagnostic accuracy and patient outcomes.
The continuous innovation in Positron Emission Tomography technology greatly propels the US Positron Emission Tomography Devices Market Industry. With advancements in detector technology, software enhancements, and integration with other imaging modalities, manufacturers are producing highly efficient and patient-friendly PET devices. Major companies like Siemens Healthineers and Philips Healthcare are developing state-of-the-art devices that minimize radiation doses while improving image quality.
The US Food and Drug Administration has actively encouraged innovation in diagnostic devices, approving several next-generation PET systems in the past few years, which has fueled market growth significantly. It is estimated that technological innovations have contributed to a 20% increase in the overall efficiency of PET scans, thus boosting their adoption in clinical settings.
In the US, governmental policies aimed at improving healthcare infrastructure significantly affect the growth of the Positron Emission Tomography Devices Market Industry. The Affordable Care Act has expanded coverage for various diagnostic imaging procedures, leading to increased utilization of PET devices. Additionally, the Centers for Medicare & Medicaid Services has recognized the value of PET in certain outlined diagnoses, providing reimbursements that encourage hospitals and clinics to incorporate this essential technology.
This has resulted in an estimated 30% increase in PET usage among eligible patients since the policy implementations, showcasing the vital role of government mandates in propelling market expansion.
The US Positron Emission Tomography Devices Market is witnessing significant advancements across various applications, notably in the fields of Oncology, Cardiology, Neurology, and Infectious Diseases. The market growth in these areas is driven by the increasing prevalence of chronic diseases, escalating healthcare demands, and technological advancements that enhance imaging efficiency and accuracy. In Oncology, Positron Emission Tomography (PET) plays a crucial role in cancer diagnosis and treatment planning, allowing for earlier detection and more effective management of tumors. This application not only aids in localizing cancers but also helps in monitoring the patient’s response to therapy, thus expanding its significance in clinical practices.
In Cardiology, the use of PET has been instrumental in the assessment of myocardial perfusion and viability. Cardiovascular diseases are the leading cause of mortality in the US, prompting a greater need for imaging modalities that provide detailed insights into heart function and conditions. As a result, PET’s ability to offer non-invasive evaluations of cardiac health is becoming increasingly vital. Similarly, in Neurology, PET is gaining traction for its capability to diagnose neurological disorders such as Alzheimer’s disease and other dementias. The ability to visualize brain activity and metabolic processes offers unprecedented insights into various neurological conditions, enhancing treatment approaches and patient outcomes.
The application of PET in Infectious Diseases is also growing, allowing healthcare professionals to identify and evaluate the severity of infections. With the rise of infectious diseases, especially in the wake of global pandemics, the ability to diagnose accurately and swiftly has become a crucial focus in the healthcare system. The demand for advanced imaging techniques that can help establish quick diagnoses further solidifies the importance of PET in this segment. The diversity of applications within the US Positron Emission Tomography Devices Market reflects the technology's versatility and its critical role in various domains of medicine. As research and development continue to advance, the integration of PET in these key applications is expected to evolve, bringing forth new opportunities for improved patient care and treatment efficacy.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Positron Emission Tomography Devices Market is characterized by a diverse range of product types, which play essential roles in diagnostic imaging and clinical applications. Integrated PET-CT Systems have gained traction due to their ability to combine metabolic and anatomical imaging, providing clinicians with enhanced diagnostic capabilities that contribute to more accurate treatment planning. Similarly, Standalone PET Systems are valued for their specific applications in nuclear medicine, particularly in oncology, where they offer high sensitivity for detecting malignancies.
Meanwhile, PET-MRI Systems are emerging as innovative imaging solutions, combining the strengths of PET and MRI to provide superior soft tissue contrast and functional imaging, thereby holding significant potential in precision medicine. The growth of these product types is driven by advances in technology and increasing demand for early disease detection, particularly in the US, where healthcare providers are focusing on improving patient outcomes. Such segments not only highlight the ongoing trends towards more integrative and specialized imaging solutions but also underline the opportunities for innovation in the rapidly evolving US Positron Emission Tomography Devices Market.
The US Positron Emission Tomography Devices Market is characterized by a diverse range of end users, primarily consisting of hospitals, diagnostic imaging centers, and research institutes. Hospitals play a critical role in the adoption of positron emission tomography devices, given their need for precise diagnostic capabilities and enhanced patient care. Diagnostic imaging centers are also significant contributors, as they specialize in advanced imaging techniques and cater to a growing population seeking outpatient services. Research institutes are crucial for driving innovation, focusing on clinical applications and advancements in medical imaging technologies.
The increasing prevalence of chronic diseases, alongside rising healthcare expenditures, drives the demand for these devices across the end-user segments. Moreover, advancements in technology and improved imaging procedures bolster the significance of these sectors in the US Positron Emission Tomography Devices Market. As each of these end users seeks to enhance diagnostic accuracy and improve patient outcomes, they continue to influence market growth and technological advancements in the industry, reflecting the crucial role they play in the overall healthcare ecosystem.
The Technology segment of the US Positron Emission Tomography Devices Market comprises various advanced imaging technologies, which play a vital role in enhancing diagnostic accuracy and patient outcomes. Time-of-Flight PET is gaining traction due to its ability to provide improved spatial resolution and signal-to-noise ratio, which is essential for accurate imaging of complex medical conditions. The Digital PET technology is becoming increasingly significant as it offers better image quality and faster processing times, making it a preferred choice in hospitals and diagnostic centers.
Analog PET continues to maintain relevance for specific applications, especially in facilities that require cost-effective solutions while still delivering reliable imaging results. The continual advancements and innovations within these technologies are driven by a growing emphasis on early disease detection and personalized medicine, positioning the US as a leader in the development of PET technologies. Furthermore, as healthcare providers adapt to evolving patient needs and technological improvements, the integration of these PET devices into clinical practice is expected to rise, influencing overall market dynamics.
The US Positron Emission Tomography Devices Market is characterized by rapid advancements and a competitive landscape that is constantly evolving. Numerous players are vying for market share, each aiming to innovate and provide state-of-the-art solutions for diagnostic imaging. This market features a combination of established firms and newer entrants, all of whom are investing in research and development to enhance image quality, reduce radiation exposure, and improve patient comfort. The increasing demand for early disease detection and the growing prevalence of cancer and cardiovascular diseases have spurred companies to focus on introducing technology that can provide more accurate outcomes. Furthermore, strategic partnerships, mergers, and acquisitions are prevalent as firms seek to bolster their market positions through synergy, enhanced product offerings, and expanded distribution channels.
Hologic has established a significant presence in the US Positron Emission Tomography Devices Market, leveraging its strong brand and industry expertise. The company is well-known for its pioneering efforts in diagnostic imaging systems, particularly in the fields of breast health and gynecological diagnostics. Hologic's strengths lie in its commitment to innovation and quality, which enables it to deliver advanced PET solutions that meet the needs of healthcare providers and patients alike. With a robust portfolio of products, Hologic has successfully integrated advanced imaging technologies with a focus on improving patient outcomes, allowing it to stand out within this competitive sector. Their strategic approach, including strong research collaboration and active investments in technology, further enhances their position in the market.
Dilon Technologies plays a significant role in the US Positron Emission Tomography Devices Market, particularly noted for its innovative contributions to molecular imaging. The company's primary focus is on providing high-quality gamma cameras that are pivotal in the early detection of cancer. Dilon's strength lies in its ability to develop compact and highly efficient PET technology, which is specifically designed for breast imaging and other diagnostic applications. The company has gained a competitive edge through strategic mergers and acquisitions that have expanded its technological capabilities and product range, allowing for enhanced diagnostic services. By maintaining a strong market presence, Dilon Technologies is committed to providing advanced imaging solutions that contribute to improved patient management and treatment options. Overall, its dedication to innovation and quality underpins its impact within the US market, strengthening its capabilities and partnerships in this dynamic healthcare landscape.
The US Positron Emission Tomography Devices Market is currently experiencing notable developments, particularly in terms of technological advancements and mergers. In August 2023, Siemens Healthineers announced the launch of a new, state-of-the-art PET/CT scanner aimed at improving diagnostic accuracy, which has garnered significant attention within the medical community. Meanwhile, in September 2023, Canon Medical Systems unveiled a versatile imaging platform that enhances PET imaging capabilities, pushing the market towards higher efficiency and resolution.
Notably, in April 2022, Hologic made headlines with their acquisition of a leading imaging company, expanding their portfolio and presence in the oncology imaging sector. The market witnessed a notable valuation growth, reaching approximately $1.5 billion in early 2023, largely fueled by the increasing demand for cancer diagnostics and advancements in radiopharmaceuticals. Additionally, Philips Healthcare has been investing heavily in Research and Development to integrate AI technologies into their PET offerings, further revolutionizing their products. Over the past few years, companies such as Medtronic and General Electric have focused on developing innovative solutions tailored to enhance patient outcomes, showcasing the dynamic nature of the US Positron Emission Tomography Devices Market.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 548.1(USD Million) |
| MARKET SIZE 2024 | 581.7(USD Million) |
| MARKET SIZE 2035 | 1132.85(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.247% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Hologic, Dilon Technologies, AgfaGevaert, Biosensors International, Medtronic, Elekta, Siemens Healthineers, Varian Medical Systems, Toshiba Medical Systems, Canon Medical Systems, Fujifilm, General Electric, Hitachi Medical Systems, Carestream Health, Philips Healthcare |
| SEGMENTS COVERED | Application, Product Type, End User, Technology |
| KEY MARKET OPPORTUNITIES | Technological advancements in imaging, Growing demand for early diagnosis, Increased prevalence of chronic diseases, Expansion of radiopharmaceuticals, Rising investment in healthcare infrastructure |
| KEY MARKET DYNAMICS | Technological advancements, Increasing cancer prevalence, Growing aging population, Rising demand for early diagnosis, Expanding healthcare infrastructure |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Positron Emission Tomography Devices Market is expected to be valued at 581.7 million USD in 2024.
By 2035, the market is projected to reach 1132.85 million USD.
The market is expected to grow at a CAGR of 6.247% during the period from 2025 to 2035.
Oncology is expected to dominate the market with a value of 440.27 million USD by 2035.
The market size for the Cardiology application is expected to reach 285.15 million USD by 2035.
Major players in the market include Hologic, Siemens Healthineers, Philips Healthcare, and General Electric.
The Neurology application segment is expected to achieve a market size of 227.57 million USD by 2035.
The Infectious Diseases application is projected to be valued at 179.86 million USD in 2035.
Key growth drivers include advances in imaging technology and increasing demand for early disease diagnosis.
The current market landscape presents opportunities for technological advancements and increased focus on patient-centered care.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
